Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Washington University School of Medicine
Scripps Translational Science Institute
Roswell Park Cancer Institute
CHU de Reims
Children's Cancer Group, China
Wake Forest University Health Sciences
Columbia University
New York Medical College
Ann & Robert H Lurie Children's Hospital of Chicago
Columbia University